Advertisement
Fecal immunochemical tests can consistently detect colorectal cancer when used on an annual basis

Consistent CRC Detection Seen for Fecal Immunochemical Tests

0
Effectiveness of the test varies between 73 and 78 percent in years two through four
Given the current political climate and issues of bipartisan concern

Possibility for Health Care Legislation Changes in 2016

0
Bipartisan issues could be on agenda, including elimination of proposed tax on medical devices
New recommendations

New Position Paper Developed for Introduction of Gluten in Infancy

0
Gluten may be introduced between 4 and 12 months; earlier introduction tied to earlier development of CD
Nearly one in seven colorectal cancer patients are under 50

About 1 in 7 Colorectal Cancer Patients Younger Than 50

0
And younger patients more likely to have advanced-stage cancer

ASCO Gastrointestinal Cancers Symposium, Jan. 21-23

0
The ASCO 2016 Gastrointestinal Cancers Symposium The American Society of Clinical Oncology's 12th annual Gastrointestinal Cancers Symposium was held from Jan. 21 to...
Curcumin can attenuate acetaminophen-induced mitochondrial alterations in the livers of mice

Curcumin Cuts Acetaminophen-Induced Hepatotoxicity in Mice

0
Protective effect of curcumin linked to attenuation of mitochondrial dysfunction
The birth defect gastroschisis among U.S. infants has increased over the past 18 years

CDC: Increasing Rate of Gastroschisis Seen in U.S.

0
Largest estimated increase over the 18 year period observed for young, non-Hispanic black mothers
More Americans than ever are satisfied with their visits to the doctor

Patient Satisfaction With Doctors May Be on the Rise

0
Physician's expertise, time spent in exam room, and online access to info were key factors in trend
Colon tumors that don't produce the protein CDX2 are more likely to recur following surgical removal in patients with stage II colon cancer

CDX2-Negative Colon Cancer May Need More Tx Post Surgery

0
Patients with CDX2-negative tumors more likely to benefit from chemo in addition to surgery
Eluxadoline (Viberzi) for irritable bowel syndrome with diarrhea seems to reduce symptoms for some patients for at least six months

Eluxadoline Eases Pain and Diarrhea for Some With IBS

0
Medication was approved recently by the U.S. Food and Drug Administration